Dietary Supplement Recall Issued Due to Anabolic Steroids

Officials with Genetic Edge Compounds are voluntarily recalling all lot codes distributed between Feb. 2, 2015 and May 2, 2017 of GEC Laxoplex dietary supplement capsules after an FDA analysis revealed the capsules to be tainted with anabolic steroids and steroid like substances.

GEC Laxoplex is marketed as a dietary supplement and sold as a muscle enhancing agent in a white plastic bottle containing 60 capsules. The product is packaged with UPC code 0058049984 and can be identified by GEC Laxoplex. GEC Laxoplex was distributed nationwide in the United States through various nutritional supplement retail outlets.

Use or consumption of products containing anabolic steroids may cause acute liver injury, which is known to be a possible harmful effect of using steroid containing products. In addition, abuse of anabolic steroids may cause shrinkage of the testes and male infertility, masculinization of women, breast enlargement in males, short stature in children, a higher predilection to misuse of other drugs and alcohol, adverse effects on blood lipid levels, and increased risk of heart attack, stroke, and death. To date, Genetic Edge Compounds has not received any reports of these or any other adverse effects related to this recall, according to a statement from the company.¹

Consumers with questions regarding this recall can contact Genetic Edge Compounds by phone at (972) 742-6311 on Monday through Friday from 9 am to 5 pm Central Standard Time. Consumers should contact their physician or health care provider if they have experienced any adverse events.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program at www.fda.gov/medwatch/report.htm.

Reference

Genetic Edge Compounds issues voluntary nationwide recall of GEC Laxoplex Dietary Supplement Capsules due to presence of anabolic steroids [news release]. Mckinney, Texas. Genetic Edge Compounds. https://www.fda.gov/Safety/Recalls/ucm557125.htm. Accessed May 6, 2017.